Dr. Burzynski the Movie Part II

Story at-a-glance

  • Burzynski—Cancer is Serious Business details the struggles and victories of Dr. Burzynski and his groundbreaking cancer treatment, and explores the current status of Antineoplastons’ clinical testing
  • Antineoplastons are peptides and derivatives of amino acids that act as genetic switches. They turn off the oncogenes that cause cancer, and turn on or activate tumor suppressor genes—genes that fight cancer
  • Dr. Burzynski’s treatment holds the first cures ever for brainstem glioma, a fatal type of brain cancer that typically affects children and young adults
  • Japanese researchers have spent 27 years independently testing Antineoplastons and reproducing Dr. Burzynski’s findings, leading them to conclude that the effectiveness of Antineoplastons is “obviously not anecdotal anymore”
  • A group of patients and patient advocates have launched a campaign to have Antineoplastons accepted worldwide as a “standard of care” for the treatment of cancer